cGxP.wire https://validator.w3.org/feed/docs/rss2.html RedHill Advances Opaganib for Ebola Outbreak Response Veloxis Begins Phase 2 Trial of Pegrizeprument Eisai and Biogen Advance LEQEMBI Access in Canada PMV Pharma Reports 46% ORR in Ovarian Cancer Trial Teva Advances U.S. Deal on Affordable Medicines and Supply AN2 Therapeutics Highlights Epetraborole Data for PV at SOHO Arch Biopartners Gains U.S. IRB Approval for LSALT Phase II AIM ImmunoTech Wins U.S. Patent for Ampligen Cancer Therapy BridgeBio Expands U.S. Access to Rare Disease Medicines Lilly to Acquire Merida in $2.875B Immunology Deal BeOne Medicines Expands U.S. Cancer Access and Manufacturing Amarin Highlights New REDUCE-IT Data at ESC 2026 PharmaEssentia Wins FDA Approval for BESREMi in ET Karmanos Offers FDA-Approved Daraxonrasib for Cancer Lilly’s Taltz and Zepbound Show One-Year Benefits RedHill Divests Talicia to Apotex for $18 Million GE HealthCare Photonova Spectra Gains CE Mark for CT IDEAYA’s IDE849 Advances Toward Phase 3 in Lung Cancer Beyond Air Wins FDA Breakthrough Device Status for LungFit GO Amgen Shows Repatha Reduces Death Risk in High-Risk Patients Alvotech Wins FDA Review Acceptance for AVT80 Biosimilar Jazz Reports Survival Benefit for Ziihera in GEA BeOne Reports New Phase 3 Survival Data for ZIIHERA Karyopharm Seeks FDA Nod for XPOVIO in Myelofibrosis FDA Approves Gilead’s Bixlenvo for HIV Treatment Vesalio’s enVast Meets NATURE Trial Endpoint in STEMI Bayer Reports Phase 3 PET Data in Cardiac Amyloidosis AskBio Advances Heart Failure Gene Therapy in Phase 2 Ascletis Starts Phase III Trial of Oral GLP-1 Drug Moderna Wins FDA Approval for 2026-27 COVID Vaccines Protagonist Therapeutics Wins FDA Approval for MIMRYLO Tenax Therapeutics Reports LEVEL Data at ESC Congress 2026 Cytokinetics Highlights Phase 3 Aficamten Data at ESC Bristol Myers Squibb Reports Five-Year Camzyos Data BridgeBio Pharma Reports New Acoramidis Data at ESC 2026 Alnylam Presents ATTR-CM Data at ESC Congress 2026 Takeda Wins FDA Approval for MIMRYLO in Polycythemia Vera Arrowhead Reports Phase 3 Plozasiran Data Reducing Pancreatitis HUTCHMED Reports Phase III SANOVO PFS Benefit in EGFR NSCLC Priovant Reports Skin Benefits of Brepocitinib in Phase 3 Natera Partners With Susan G. Komen to Advance Breast Cancer Awareness Acadia Pharmaceuticals’ DAYBU Approved in EU for Rett Syndrome Shionogi Expands Fetroja Role in U.S. Drug-Resistance Preparedness CRISPR Therapeutics Reports Durable CTX310 Lipid Lowering Roche Wins FDA Clearance for Elecsys pTau217 Test United Therapeutics Advances PAH and IPF Data at ESC, ERS Takeda Wins Japan Approval for ORZEYFUL in Narcolepsy GSK Wins Japan Approval for Hibsago in Hepatitis B Agenus Reports Durable BOT+BAL Activity in MSS Colorectal Cancer Amarin Reports Potential Legacy Effect of Icosapent Ethyl in New REDUCE-IT Analysis